MC1344A1 - Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques - Google Patents

Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques

Info

Publication number
MC1344A1
MC1344A1 MC801462A MC1462A MC1344A1 MC 1344 A1 MC1344 A1 MC 1344A1 MC 801462 A MC801462 A MC 801462A MC 1462 A MC1462 A MC 1462A MC 1344 A1 MC1344 A1 MC 1344A1
Authority
MC
Monaco
Prior art keywords
group
pyrrolidinone
methoxybenzoyl
formula
compounds
Prior art date
Application number
MC801462A
Other languages
English (en)
French (fr)
Inventor
W Aschwanden
E Kiburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1344A1 publication Critical patent/MC1344A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MC801462A 1979-08-09 1980-08-07 Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques MC1344A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH730879 1979-08-09
CH475580 1980-06-20

Publications (1)

Publication Number Publication Date
MC1344A1 true MC1344A1 (fr) 1981-06-22

Family

ID=25696222

Family Applications (1)

Application Number Title Priority Date Filing Date
MC801462A MC1344A1 (fr) 1979-08-09 1980-08-07 Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques

Country Status (38)

Country Link
US (1) US4461906A (enExample)
EP (1) EP0024030B1 (enExample)
KR (2) KR850000845B1 (enExample)
AR (1) AR230625A1 (enExample)
AT (1) ATE2894T1 (enExample)
AU (1) AU538686B2 (enExample)
BG (1) BG34612A3 (enExample)
CA (1) CA1124247A (enExample)
CS (1) CS214837B2 (enExample)
CU (1) CU35300A (enExample)
DD (1) DD152337A5 (enExample)
DE (2) DE3062531D1 (enExample)
DK (1) DK159679C (enExample)
ES (2) ES494091A0 (enExample)
FI (1) FI70572C (enExample)
FR (1) FR2463127A1 (enExample)
GB (1) GB2055835B (enExample)
GR (1) GR69911B (enExample)
HK (1) HK18486A (enExample)
HU (1) HU180596B (enExample)
IE (1) IE50090B1 (enExample)
IL (1) IL60733A (enExample)
IN (1) IN153082B (enExample)
IT (1) IT1131959B (enExample)
LU (1) LU82692A1 (enExample)
MC (1) MC1344A1 (enExample)
MY (1) MY8500273A (enExample)
NL (1) NL8004025A (enExample)
NO (1) NO154632C (enExample)
NZ (1) NZ194558A (enExample)
OA (1) OA06624A (enExample)
PH (1) PH16220A (enExample)
PL (1) PL127472B1 (enExample)
PT (1) PT71686B (enExample)
RO (1) RO82358B (enExample)
SE (1) SE8005607L (enExample)
YU (1) YU42516B (enExample)
ZW (1) ZW16680A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
US4560700A (en) * 1985-02-08 1985-12-24 Merrell Dow Pharmaceuticals Inc. Pyrrole-3-carboxylate cardiotonic agents
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
US5049577A (en) * 1990-01-29 1991-09-17 E. R. Squibb & Sons, Inc. 2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith
US5049578A (en) * 1990-03-09 1991-09-17 E. R. Squibb & Sons, Inc. 1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
WO1997039750A1 (en) * 1996-04-19 1997-10-30 The Regents Of The University Of California Treatment of mood/affective disorders by glutamatergic upmodulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
DE2541855A1 (de) * 1975-09-18 1977-03-31 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives

Also Published As

Publication number Publication date
PT71686A (en) 1980-09-01
SE8005607L (sv) 1981-02-10
KR830003420A (ko) 1983-06-20
IL60733A (en) 1984-03-30
ATE2894T1 (de) 1983-04-15
IL60733A0 (en) 1980-10-26
EP0024030A1 (de) 1981-02-18
AU6099680A (en) 1981-02-12
KR850001457A (ko) 1985-03-18
NO154632B (no) 1986-08-11
ZW16680A1 (en) 1981-03-04
MY8500273A (en) 1985-12-31
IN153082B (enExample) 1984-05-26
DK338480A (da) 1981-02-10
BG34612A3 (bg) 1983-10-15
NZ194558A (en) 1984-07-06
CU35300A (en) 1982-03-28
PT71686B (en) 1982-01-22
RO82358B (ro) 1984-03-30
HK18486A (en) 1986-03-27
PL226164A1 (enExample) 1981-08-07
US4461906A (en) 1984-07-24
NO154632C (no) 1986-11-19
PL127472B1 (en) 1983-10-31
HU180596B (en) 1983-03-28
KR850000843B1 (ko) 1985-06-17
ES8106290A1 (es) 1981-08-01
IE801676L (en) 1981-02-09
ES8301209A1 (es) 1982-12-01
FR2463127B1 (enExample) 1983-08-12
CS214837B2 (en) 1982-06-25
PH16220A (en) 1983-08-09
AR230625A1 (es) 1984-05-31
YU42516B (en) 1988-10-31
DE3029671A1 (de) 1981-02-26
DD152337A5 (de) 1981-11-25
DE3062531D1 (en) 1983-05-05
IT1131959B (it) 1986-06-25
GB2055835B (en) 1983-07-06
NL8004025A (nl) 1981-02-11
IT8023391A0 (it) 1980-07-11
NO802370L (no) 1981-02-10
FR2463127A1 (fr) 1981-02-20
EP0024030B1 (de) 1983-03-30
FI70572B (fi) 1986-06-06
GR69911B (enExample) 1982-07-21
ES500381A0 (es) 1982-12-01
DK159679B (da) 1990-11-19
KR850000845B1 (ko) 1985-06-17
LU82692A1 (de) 1982-05-10
AU538686B2 (en) 1984-08-23
FI802417A7 (fi) 1981-02-10
FI70572C (fi) 1986-09-24
ES494091A0 (es) 1981-08-01
YU200680A (en) 1983-09-30
OA06624A (fr) 1981-08-31
DK159679C (da) 1991-04-15
GB2055835A (en) 1981-03-11
CA1124247A (en) 1982-05-25
RO82358A (ro) 1984-03-15
IE50090B1 (en) 1986-02-05

Similar Documents

Publication Publication Date Title
EP0162036B1 (fr) (S)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
EP0165919B1 (fr) (R)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
EP0018342A1 (fr) Nouveaux dérivés du glycerol, leurs procédés de préparation ainsi que les compositions pharmaceutiques les contenant
LU87414A1 (fr) Derives de l'adenosine
MC1257A1 (fr) Derive pyrrolidinique
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
FR2515179A1 (fr) Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
MC1618A1 (fr) Steroides
FR2601016A1 (fr) Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
EP0138721A2 (fr) Nouveaux benzenesulfonyl-lactames, leur procédé de préparation et leur application comme substance active de compositions pharmaceutiques
FR2621587A1 (fr) Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
BE1004995A3 (fr) Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer.
BE1008622A3 (fr) Derives de l'epi-epibatidine.
FR2568248A1 (fr) Nouveaux composes naphtaleniques, leur preparation et leur application comme medicaments
EP0869952B1 (fr) Derives de 5-naphtalen-1-y1-1,3-dioxanes, leur preparation et leur application en therapeutique
EP0271404B1 (fr) Nouveaux dérivés du pyrrole, leur préparation et les compositions pharmaceutiques qui les contiennent
EP0294295B1 (fr) Dérivés de la 1-arylsulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
BE884145R (fr) Composes indoliques nouveaux
FR2495615A1 (fr) Ethers d'hydroxymethylpyrazines substituees, leur preparation et leur utilisation therapeutique en tant qu'agents antilipolytiques, hypotriglyceridemiques et hypocholesterolemiques
BE862019R (fr) Nouveaux derives de la vincamine, leur preparation et leur application comme medicaments
FR2695389A1 (fr) Nouveau dérivé de l'isoindolinone, sa préparation et les compositions pharmaceutiques qui le contiennent.
FR2714055A1 (fr) Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique.
MC1366A1 (fr) Nouvelles oxazolines

Legal Events

Date Code Title Description
YP Annual fee paid